Multiple scores validate long-term type-2 diabetes mellitus (T2DM) remission after metabolic and bariatric surgery (MBS). However, studies comparing Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) have not adequately controlled for certain parameters, which may influence procedure selection.
Methods
We conducted a multicenter retrospective review of patients with T2DM who underwent RYGB or SG between 2008 and 2017. Data on demographics, clinical, laboratory, and metabolic values were collected annually for up to 14 years. Each eligible RYGB patient was individually matched to an eligible SG patient based on diabetes severity, weight loss, and follow-up duration.
Results
Among 1149 T2DM patients, 467 were eligible for matching. We found 97 matched pairs who underwent RYGB or SG. RYGB showed significantly higher T2DM remission rates (46.4%) compared to SG (33.0%) after matching. SG patients had higher insulin usage (35.1%) than RYGB patients (20.6%). RYGB patients also experienced greater decreases in HbA1c levels and diabetes medication usage than SG patients.
Conclusions
RYGB demonstrates higher efficacy for T2DM remission compared to SG, regardless of baseline characteristics, T2DM severity, weight loss, and follow-up duration. Further studies are needed to understand the long-term metabolic effects of MBS and the underlying pathophysiology of T2DM remission after MBS.
ChooiYCDingCMagkosF. The epidemiology of obesity. Metabolism. 2019;92:6-10.
2.
GhusnWIkemiyaKAl AnnanKAcostaADayyehBKALeeE, et al.Diabetes mellitus remission in patients with BMI > 50 kg/m2 after bariatric surgeries: a real-world multi-centered study. Obes Surg. 2023;33(6):1838-1845.
3.
NianogoRAArahOA. Forecasting obesity and type 2 diabetes incidence and burden: the ViLA-obesity simulation model. Front Public Health. 2022;10:818816.
4.
Galicia-GarciaUBenito-VicenteAJebariSLarrea-SebalASiddiqiHUribeKB, et al.Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.
5.
ClappBGrassoSGamezJEdwardsJDodooCPortelaR, et al.Does accreditation matter? An analysis of complications of bariatric cases using the metabolic and bariatric surgery accreditation and quality improvement program and national quality improvement program databases. Surg Obes Relat Dis. 2022;18(5):658.
6.
NakanishiHTeixeiraAFMatarRHHageKAcostaAJAbu DayyehBK, et al.Impact on mid-term health-related quality of life after duodenal switch: a systematic review and meta-analysis. Obes Surg. 2023;33(3):769.
7.
SchauerPRBhattDLKirwanJPWolskiKBrethauerSANavaneethanSD, et al.Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014;370(21):2002.
8.
VahibeALiviaCPortelaRShahMMcKenzieTKelloggT, et al.Diabetes remission after bariatric surgery in patients on glucocorticoids: a pilot study. Surg Laparosc Endosc Percutan Tech. 2021;32(2):236.
9.
BalamuruganGLeoSJSivagnanamSTBalaji PrasadSRavindraCRenganV, et al.Comparison of efficacy and safety between roux-en-Y gastric bypass (RYGB) vs one anastomosis gastric bypass (OAGB) vs single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S): a systematic review of bariatric and metabolic surgery. Obes Surg. 2023;33(7):2194.
10.
ClappBPonceJDeMariaEGhanemOHutterMKothariS, et al.American Society for Metabolic and Bariatric Surgery 2020 estimate of metabolic and bariatric procedures performed in the United States. Surg Obes Relat Dis. 2022;18(9):1134.
11.
AminianABrethauerSAAndalibANowackiASJimenezACorcellesR, et al.Individualized metabolic surgery score: procedure selection based on diabetes severity. Ann Surg. 2017;266(4):650.
12.
GhusnWMaPIkemiyaKHageKAbboudDMVierkantRA, et al.The role of diabetes severity scores in predicting disease remission in patients with BMI > 50 kg/m2 undergoing Roux-En-Y gastric bypass and sleeve gastrectomy: a multi-centered study. Surg Endosc. 2023;37(9):7114-7120.
13.
LeeWJHurKYLakadawalaMKasamaKWongSKHChenSC, et al.Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013;9(3):379.
14.
XinYYWangfengGXuNWangliF. Correlation between postoperative weight loss and diabetes mellitus remission: a meta-analysis. Obes Surg. 2014;24(11):1862.
15.
InzucchiSE. Clinical practice. Diagnosis of diabetes. N Engl J Med. 2012;367(6):542.
16.
RiddleMCCefaluWTEvansPHGersteinHCNauckMAOhWK, et al.Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care. 2021;44(10):2438.
17.
LiPFuPChenJWangLHWangDR. Laparoscopic Roux-en-Y gastric bypass vs. laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus: a meta-analysis of sixteen recent studies. Hepatogastroenterology. 2013;60(121):132.
18.
HofsøDFatimaFBorgeraasHBirkelandKIGulsethHLHertelJK, et al.Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7(12):912.
19.
SvanevikMLorentzenJBorgeraasHSandbuRSeipBMedhusAW, et al.Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trial. Lancet Diabetes Endocrinol. 2023;11(8):555.
20.
SalminenPHelmiöMOvaskaJJuutiALeivonenMPeromaa-HaavistoP, et al.Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-Y gastric bypass on weight loss at 5 Years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319(3):241.
21.
PeterliRWölnerhanssenBKPetersTVetterDKröllDBorbélyY, et al.Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255.
22.
AminianAVidalJSalminenPStillCDNor HanipahZSharmaG, et al.Late relapse of diabetes after bariatric surgery: not rare, but not a failure. Diabetes Care. 2020;43(3):534.
23.
Chumakova-OrinMVanettaCMorisDPGuerronAD. Diabetes remission after bariatric surgery. World J Diabetes. 2021;12(7):1093.
24.
Pérez-PevidaBEscaladaJMirasADFrühbeckG. Mechanisms underlying type 2 diabetes remission after metabolic surgery. Front Endocrinol (Lausanne). 2019;10:641.
25.
LeanMELeslieWSBarnesACBrosnahanNThomGMcCombieL, et al.Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541.
26.
BuchwaldHAvidorYBraunwaldEJensenMDPoriesWFahrbachK, et al.Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724.
27.
SjöholmKCarlssonLMSTaubeMle RouxCWSvenssonPAPeltonenM. Comparison of preoperative remission scores and diabetes duration alone as predictors of durable type 2 diabetes remission and risk of diabetes complications after bariatric surgery: a post hoc analysis of participants from the Swedish obese subjects study. Diabetes Care. 2020;43(11):2804.
28.
GhusnWHurtadoMDAcostaA. Weight-centric treatment of type 2 diabetes mellitus. Obesity Pillars. 2022;4:100045.
29.
ChoYM. A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery. Diabetes Metab J. 2014;38(6):406.
30.
JiménezACasamitjanaRFloresLViaplanaJCorcellesRLacyA, et al.Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg. 2012;256(6):1023.
31.
RomeroFNicolauJFloresLCasamitjanaRIbarzabalALacyA, et al.Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc. 2012;26(8):2231.
32.
GuidaCStephenSDWatsonMDempsterNLarraufiePMarjotT, et al.PYY plays a key role in the resolution of diabetes following bariatric surgery in humans. EBioMedicine. 2019;40:67-76.
33.
PournarasDJle RouxCW. Are bile acids the new gut hormones? Lessons from weight loss surgery models. Endocrinology. 2013;154(7):2255.
34.
PrawittJCaronSStaelsB. Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep. 2011;11(3):160.
35.
Singer-EnglarTBarlowGMathurR. Obesity, diabetes, and the gut microbiome: an updated review. Expert Rev Gastroenterol Hepatol. 2019;13(1):3-15.
36.
DebédatJClémentKAron-WisnewskyJ. Gut microbiota dysbiosis in human obesity: impact of bariatric surgery. Curr Obes Rep. 2019;8(3):229.
37.
IlhanZEDiBaiseJKDautelSEIsernNGKimYMHoytDW, et al.Temporospatial shifts in the human gut microbiome and metabolome after gastric bypass surgery. NPJ Biofilms Microbiomes. 2020;6(1):12.
38.
ChambersESViardotAPsichasAMorrisonDJMurphyKGZac-VargheseSEK, et al.Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64(11):1744.
39.
TanHCHsuJWKovalikJPEngAChanWHKhooCM, et al.Branched-chain amino acid oxidation is elevated in adults with morbid obesity and decreases significantly after sleeve gastrectomy. J Nutr. 2020;150(12):3180.
40.
SvaneMSBojsen-MøllerKNMartinussenCDirksenCMadsenJLReitelsederS, et al.Postprandial nutrient handling and gastrointestinal hormone secretion after roux-en-Y gastric bypass vs sleeve gastrectomy. Gastroenterology. 2019;156(6):1627-1641.
41.
Bozadjieva KramerNEversSSShinJHSilverwoodSWangYBurantCF, et al.The role of elevated branched-chain amino acids in the effects of vertical sleeve gastrectomy to reduce weight and improve glucose regulation. Cell Rep. 2020;33(2):108239.
42.
WalleniusVDirinckEFändriksLMaleckasAle RouxCWThorellA. Glycemic control after sleeve gastrectomy and roux-en-Y gastric bypass in obese subjects with type 2 diabetes mellitus. Obes Surg. 2018;28(6):1461.
43.
DavisDBKhorakiJZiemelisMSirinvaravongSHanJYCamposGM. Roux en Y gastric bypass hypoglycemia resolves with gastric feeding or reversal: confirming a non-pancreatic etiology. Mol Metab. 2018;9:15-27.
44.
VetterMLRitterSWaddenTASarwerDB. Comparison of bariatric surgical procedures for diabetes remission: efficacy and mechanisms. Diabetes Spectr. 2012;25(4):200.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
